XML 17 R3.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 24,594 $ 57,445
Marketable securities (Notes 4 and 14) 146,655 133,044
Trade and other receivables, net of allowance for credit losses of $223 and $223, as of June 30, 2024 and December 31, 2023, respectively 9,548 816
Inventories (Note 5) 23,524 38,868
Prepaid expenses and other current assets 3,985 2,522
Total current assets 208,306 232,695
Mineral properties, net (Note 6) 123,840 119,581
Property, plant and equipment, net (Note 6) 40,356 26,123
Inventories (Note 5) 6,887 1,852
Operating lease right of use asset 1,127 1,219
Investments 3,473 1,356
Other long-term receivables 1,482 1,534
Restricted cash (Note 7) 17,924 17,579
Total assets 403,395 401,939
Current liabilities    
Accounts payable and accrued liabilities (Note 12) 7,147 10,161
Operating lease liability 218 199
Total current liabilities 7,365 10,360
Operating lease liability 1,006 1,120
Asset retirement obligations (Note 7) 11,688 10,922
Deferred revenue 600 332
Total liabilities 20,659 22,734
Equity    
Share capital Common shares, without par value, unlimited shares authorized; shares issued and outstanding 163,661,111 and 162,659,155 as of June 30, 2024 and December 31, 2023, respectively 739,762 733,450
Accumulated deficit (359,037) (356,258)
Accumulated other comprehensive loss (1,946) (1,946)
Total shareholders' equity 378,779 375,246
Non-controlling interests 3,957 3,959
Total equity 382,736 379,205
Total liabilities and equity 403,395 401,939
Commitments and contingencies (Note 13)